Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bushen Gubiao is a Traditional Chinese Medicine (TCM) herbal formula developed by the Shanghai Hospital of Traditional Chinese Medicine, specifically formulated as granules for pediatric use. The name reflects its primary therapeutic principles in TCM: "Bushen" (tonifying the kidney) and "Gubiao" (strengthening the exterior). It is indicated for children with recurrent respiratory infections (RRI), a condition characterized by frequent bouts of pneumonia, bronchitis, or upper respiratory tract infections. The formula aims to enhance the body's underlying "qi" and defensive capabilities to reduce the frequency and severity of these infections. Clinical studies, such as those registered under ChiCTR2000037534, focus on evaluating its efficacy and safety profile in the pediatric population.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bushen gubiao.